“Pyridoxal-5-phosphate MC-1 ), blocking purinergic receptors and intracellular influx of calcium , was shown to decrease the incidence of perioperative myocardial infarction in the prospective, randomized, double-blinded MC-1 to Eliminate Necrosis and Damage in CABG (MEND-CABG) clinical trial.”